165 related articles for article (PubMed ID: 30919342)
1. ATAD3A on the Path to Cancer.
Teng Y; Lang L; Shay C
Adv Exp Med Biol; 2019; 1134():259-269. PubMed ID: 30919342
[TBL] [Abstract][Full Text] [Related]
2. Emerging Links between Control of Mitochondrial Protein ATAD3A and Cancer.
Lang L; Loveless R; Teng Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113782
[TBL] [Abstract][Full Text] [Related]
3. ATAD3 proteins: brokers of a mitochondria-endoplasmic reticulum connection in mammalian cells.
Baudier J
Biol Rev Camb Philos Soc; 2018 May; 93(2):827-844. PubMed ID: 28941010
[TBL] [Abstract][Full Text] [Related]
4. ATAD3A stabilizes GRP78 to suppress ER stress for acquired chemoresistance in colorectal cancer.
Huang KC; Chiang SF; Yang PC; Ke TW; Chen TW; Lin CY; Chang HY; Chen WT; Chao KC
J Cell Physiol; 2021 Sep; 236(9):6481-6495. PubMed ID: 33580514
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial ATAD3A regulates milk biosynthesis and proliferation of mammary epithelial cells from dairy cow via the mTOR pathway.
Chen D; Yuan X; Liu L; Zhang M; Qu B; Zhen Z; Gao X
Cell Biol Int; 2018 May; 42(5):533-542. PubMed ID: 29286187
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.
You WC; Chiou SH; Huang CY; Chiang SF; Yang CL; Sudhakar JN; Lin TY; Chiang IP; Shen CC; Cheng WY; Lin JC; Shieh SH; Chow KC
Neuro Oncol; 2013 Oct; 15(10):1342-52. PubMed ID: 24057885
[TBL] [Abstract][Full Text] [Related]
7. Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes.
Harel T; Yoon WH; Garone C; Gu S; Coban-Akdemir Z; Eldomery MK; Posey JE; Jhangiani SN; Rosenfeld JA; Cho MT; Fox S; Withers M; Brooks SM; Chiang T; Duraine L; Erdin S; Yuan B; Shao Y; Moussallem E; Lamperti C; Donati MA; Smith JD; McLaughlin HM; Eng CM; Walkiewicz M; Xia F; Pippucci T; Magini P; Seri M; Zeviani M; Hirano M; Hunter JV; Srour M; Zanigni S; Lewis RA; Muzny DM; Lotze TE; Boerwinkle E; ; ; Gibbs RA; Hickey SE; Graham BH; Yang Y; Buhas D; Martin DM; Potocki L; Graziano C; Bellen HJ; Lupski JR
Am J Hum Genet; 2016 Oct; 99(4):831-845. PubMed ID: 27640307
[TBL] [Abstract][Full Text] [Related]
8. ATAD3A has a scaffolding role regulating mitochondria inner membrane structure and protein assembly.
Arguello T; Peralta S; Antonicka H; Gaidosh G; Diaz F; Tu YT; Garcia S; Shiekhattar R; Barrientos A; Moraes CT
Cell Rep; 2021 Dec; 37(12):110139. PubMed ID: 34936866
[TBL] [Abstract][Full Text] [Related]
9. ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia.
Cooper HM; Yang Y; Ylikallio E; Khairullin R; Woldegebriel R; Lin KL; Euro L; Palin E; Wolf A; Trokovic R; Isohanni P; Kaakkola S; Auranen M; Lönnqvist T; Wanrooij S; Tyynismaa H
Hum Mol Genet; 2017 Apr; 26(8):1432-1443. PubMed ID: 28158749
[TBL] [Abstract][Full Text] [Related]
10. "ATAD3C regulates ATAD3A assembly and function in the mitochondrial membrane".
Gaudó P; de Tomás-Mateo E; Garrido-Pérez N; Santana A; Ruiz-Pesini E; Montoya J; Bayona-Bafaluy P
Free Radic Biol Med; 2024 Feb; 211():114-126. PubMed ID: 38092275
[TBL] [Abstract][Full Text] [Related]
11. Deletion of ATAD3A inhibits osteogenesis by impairing mitochondria structure and function in pre-osteoblast.
Lee H; Kim DW
Dev Dyn; 2022 Dec; 251(12):1982-2000. PubMed ID: 36000457
[TBL] [Abstract][Full Text] [Related]
12. Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis.
Wu H; Wang T; Liu Y; Li X; Xu S; Wu C; Zou H; Cao M; Jin G; Lang J; Wang B; Liu B; Luo X; Xu C
J Exp Clin Cancer Res; 2020 Dec; 39(1):274. PubMed ID: 33280610
[TBL] [Abstract][Full Text] [Related]
13. ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development.
Lang L; Loveless R; Dou J; Lam T; Chen A; Wang F; Sun L; Juarez J; Qin ZS; Saba NF; Shay C; Teng Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):43. PubMed ID: 35093151
[TBL] [Abstract][Full Text] [Related]
14. ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models.
Zhao Y; Hu D; Wang R; Sun X; Ropelewski P; Hubler Z; Lundberg K; Wang Q; Adams DJ; Xu R; Qi X
Nat Commun; 2022 Mar; 13(1):1121. PubMed ID: 35236834
[TBL] [Abstract][Full Text] [Related]
15. Sigma-1 receptor maintains ATAD3A as a monomer to inhibit mitochondrial fragmentation at the mitochondria-associated membrane in amyotrophic lateral sclerosis.
Watanabe S; Horiuchi M; Murata Y; Komine O; Kawade N; Sobue A; Yamanaka K
Neurobiol Dis; 2023 Apr; 179():106031. PubMed ID: 36736924
[TBL] [Abstract][Full Text] [Related]
16. Functional interpretation of ATAD3A variants in neuro-mitochondrial phenotypes.
Yap ZY; Park YH; Wortmann SB; Gunning AC; Ezer S; Lee S; Duraine L; Wilichowski E; Wilson K; Mayr JA; Wagner M; Li H; Kini U; Black ED; Monaghan KG; Lupski JR; Ellard S; Westphal DS; Harel T; Yoon WH
Genome Med; 2021 Apr; 13(1):55. PubMed ID: 33845882
[TBL] [Abstract][Full Text] [Related]
17. Atad3a suppresses Pink1-dependent mitophagy to maintain homeostasis of hematopoietic progenitor cells.
Jin G; Xu C; Zhang X; Long J; Rezaeian AH; Liu C; Furth ME; Kridel S; Pasche B; Bian XW; Lin HK
Nat Immunol; 2018 Jan; 19(1):29-40. PubMed ID: 29242539
[TBL] [Abstract][Full Text] [Related]
18. The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization.
Li Q; Chu Y; Li S; Yu L; Deng H; Liao C; Liao X; Yang C; Qi M; Cheng J; Chen G; Huang L
Cell Death Dis; 2022 Oct; 13(10):899. PubMed ID: 36289190
[TBL] [Abstract][Full Text] [Related]
19. Loss of mitochondrial ATPase ATAD3A contributes to nonalcoholic fatty liver disease through accumulation of lipids and damaged mitochondria.
Chen L; Li Y; Sottas C; Lazaris A; Petrillo SK; Metrakos P; Li L; Ishida Y; Saito T; Garza S; Papadopoulos V
J Biol Chem; 2022 Jun; 298(6):102008. PubMed ID: 35513069
[TBL] [Abstract][Full Text] [Related]
20. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
Dickerson T; Jauregui CE; Teng Y
Future Med Chem; 2017 Dec; 9(18):2197-2210. PubMed ID: 29182013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
